Old Web
English
Sign In
Acemap
>
Paper
>
SAFETY AND EFFICACY OF RETREATING FOLLICULAR NON-HODGKINʼS LYMPHOMA WITH 90Y IBRITUMOMAB TIUXETAN (ZEVALIN).: 330
SAFETY AND EFFICACY OF RETREATING FOLLICULAR NON-HODGKINʼS LYMPHOMA WITH 90Y IBRITUMOMAB TIUXETAN (ZEVALIN).: 330
2007
Jatin J. Shah
J. Mueh
John Lister
S. Jasthy
M Gregory
C McKay
R. Krumdieck
Andres Forero
Keywords:
Endocrinology
Lymphoma
Oncology
Follicular phase
90Y ibritumomab tiuxetan
Internal medicine
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]